Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Antiangiogenic agents

FiggWD, Pluda JM, Sartor O (1999) In Teicher BA (ed), Antiangiogenic Agents in Cancer Therapy. Humana, Totowa, NJ, p. 371... [Pg.66]

Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors... [Pg.329]

Teicher BA, Sotomayor EA, Huang ZD. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 1992 52 6702-6704. [Pg.334]

Murata R, Nishimura Y, Hiraoka M. An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma. Int J Rad Oncol Biol Phys 1997 37 1107-1113. [Pg.334]

Stopeck A. Results of a phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies. Proc Am Soc Clin Oncol 2000 19 206 (abst). [Pg.348]

The controversy surrounding the use of antiangiogenic agents during radiotherapy is based upon the concern that the resulting hypoxia will impair tumor response to radiation... [Pg.359]

ANTIANGIOGENIC AGENTS ENHANCE TUMOR CONTROL BY IONIZING RADIATION... [Pg.366]

Thalidomide (Thalomid) is a derivative of glutamic acid that is chemically related to glutethimide. It exerts a number of biological effects as an immunosuppressive, antiinflammatory, and antiangiogenic agent, yet its mechanisms of action have not been fuUy elucidated. Thalidomide potently inhibits production of tumor necrosis factor (TNF) a and interleukin (IL) 12, and its effect on these and other cytokines may account for some of its clinical effects. [Pg.490]

Bargagna-Mohan P, Hamza A, Y-e K, Ho YK, Mor-Vaknin N, Wendschlag N, Liu J, Evans RM, Markovitz DM, Zhan C-G, Kim KB, Mohan R (2007) The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin. Chem Biol 14 623-634... [Pg.82]

Angiostatin (AS) and endostatin (ES) are antiangiogenic agents with low toxicity that inhibit the VEGF-mediated migration of primary human microvascular ECs. [Pg.317]

Beliveau, R., Gingras, D., Kruger, E. A., Lamy, S., Sirois, R, et al. 2002. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. Clin. Cancer Res. 8 1242-1250. [Pg.320]

See other pages where Antiangiogenic agents is mentioned: [Pg.156]    [Pg.342]    [Pg.360]    [Pg.368]    [Pg.369]    [Pg.369]    [Pg.287]    [Pg.56]    [Pg.326]    [Pg.359]    [Pg.359]    [Pg.366]    [Pg.389]    [Pg.407]    [Pg.424]    [Pg.214]    [Pg.426]    [Pg.380]    [Pg.121]    [Pg.519]    [Pg.301]    [Pg.1278]    [Pg.107]    [Pg.340]    [Pg.341]    [Pg.343]    [Pg.213]    [Pg.222]   
See also in sourсe #XX -- [ Pg.340 ]

See also in sourсe #XX -- [ Pg.618 ]

See also in sourсe #XX -- [ Pg.5 , Pg.5 , Pg.38 , Pg.216 , Pg.217 , Pg.218 , Pg.219 ]

See also in sourсe #XX -- [ Pg.29 ]

See also in sourсe #XX -- [ Pg.26 , Pg.757 ]

See also in sourсe #XX -- [ Pg.757 ]

See also in sourсe #XX -- [ Pg.29 ]



SEARCH



Antiangiogenic

Antiangiogenics

© 2024 chempedia.info